Ajovy (fremanezumab)

pCPA File Number: 21431
Negotiation Status:
Concluded with an LOI
Indication(s):
Prevention of Migraine in Adults
Sponsor/Manufacturer:
Teva Canada Ltd.
CDA-AMC Project Number:
SR0641-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: